author · SDG 3

Publications by Srikanth Prasad Tripathy

Publications by Srikanth Prasad Tripathy at Dr. D. Y. Patil Vidyapeeth, Pune, aligned with SDG 3: Good Health and Well-being. 202 publications · page 4 of 11.

← All publications in SDG 3

1. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients
   Central Research Facility (2020)
2. Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting
   Central Research Facility · National Institute of Research in Tuberculosis · PLoS ONE (2020)
3. Spoligotype Diversity of Mycobacterium tuberculosis over Two Decades from Tiruvallur, South India
   Central Research Facility · National Institute of Research in Tuberculosis · International Journal of Microbiology (2020)
4. Vitamin D – A host directed autophagy mediated therapy for tuberculosis
   Central Research Facility · National Institute of Research in Tuberculosis · Molecular Immunology (2020)
5. Multicentric validation of indigenous molecular test Truenat™ MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards
   Central Research Facility · National Institute of Research in Tuberculosis · The Indian Journal of Medical Research (2020)
6. Evaluation of ‘TBDetect’ sputum microscopy kit for improved detection of Mycobacterium tuberculosis: a multi-centric validation study
   Central Research Facility · National Institute of Research in Tuberculosis · Clinical Microbiology and Infection (2020)
7. Deep Profiling Identifies Selection of Nonsynonymous Amino Acid Substitutions in HIV-1 Envelope During Early Infection
   Central Research Facility · National Institute of Research in Tuberculosis · AIDS Research and Human Retroviruses (2020)
8. Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
   Central Research Facility · National Institute of Research in Tuberculosis · Scientific Reports (2020)
9. Reprocessing of Contaminated MGIT 960 Cultures to Improve Availability of Valid Results for Mycobacteria
   Central Research Facility · National Institute of Research in Tuberculosis · International Journal of Microbiology (2020)
10. Characteristics of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and its influence on tuberculosis treatment outcomes in persons living with HIV
    Central Research Facility · Indian Council of Medical Research · National Institute of Research in Tuberculosis · International Journal of Infectious Diseases (2020)
11. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
    Adjunct Faculties · National Institute of Research in Tuberculosis · The Indian Journal of Medical Research (2020)
12. Subnational mapping of under-5 and neonatal mortality trends in India: the Global Burden of Disease Study 2000–17
    Orthopedics · Dermatology, Venereology & Leprosy · Adjunct Faculties · Central Research Facility · Pharmacology · Institute for Health Metrics and Evaluation · University of Washington · Public Health Foundation of India · Government of India · Ministry of Health and Family Welfare · Government of Western Australia Department of Health · Department of Health Research · Indian Council of Medical Research · The Lancet (2020)
13. Protein–protein interaction of Rv0148 with Htdy and its predicted role towards drug resistance in Mycobacterium tuberculosis
    Central Research Facility · National Institute of Research in Tuberculosis · BMC Microbiology (2020)
14. Genetic Characterization of Full-Length HIV-2 Long Terminal Repeat Sequences: Identification of Rare Promoter Variants
    Central Research Facility · Indian Council of Medical Research · AIDS Research and Human Retroviruses (2020)
15. Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India
    Central Research Facility · National Institute of Research in Tuberculosis · Indian Council of Medical Research · PLoS ONE (2020)
16. In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
    Central Research Facility · National Institute of Research in Tuberculosis · Scientific Reports (2020)
17. Association of Tuberculosis With Household Catastrophic Expenditure in South India
    Central Research Facility · Indian Council of Medical Research · JAMA Network Open (2020)
18. 4‐month moxifloxacin containing regimens in the treatment of patients with sputum‐positive pulmonary tuberculosis in South India – a randomised clinical trial
    Central Research Facility · National Institute of Research in Tuberculosis · Tropical Medicine & International Health (2020)
19. Mapping the tuberculosis scientific landscape among BRICS countries: a bibliometric and network analysis
    Central Research Facility · National Institute of Research in Tuberculosis · Memórias do Instituto Oswaldo Cruz (2020)
20. Catastrophic costs due to tuberculosis in South India: comparison between active and passive case finding
    Central Research Facility · Indian Council of Medical Research · Transactions of the Royal Society of Tropical Medicine and Hygiene (2019)